Host immunity to Mycobacterium tuberculosis and risk of tuberculosis: A longitudinal study among Greenlanders

Highlights • Immunity to promising latent TB vaccine antigens did not reduce risk of TB. • Immunity to latent TB antigens was observed among individuals categorised as not Mtb -infected. • A large follow-up study with a clinical outcome in a setting with high TB transmission. • Findings are not infl...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 34; no. 48; pp. 5975 - 5983
Main Authors Michelsen, Sascha Wilk, M.D., Ph.D, Soborg, Bolette, M.D., Ph.D, Agger, Else Marie, M.Sc., Ph.D, Diaz, Lars Jorge, M.Sc, Hoff, Soren Tetens, M.D., Ph.D, Koch, Anders, M.D., Ph.D., MPH, Sorensen, Hans Christian Florian, M.D, Andersen, Peter, D.M.Sc., DVM, Wohlfahrt, Jan, M.Sc., D.M.Sc, Melbye, Mads, M.D., D.M.Sc
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 21.11.2016
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights • Immunity to promising latent TB vaccine antigens did not reduce risk of TB. • Immunity to latent TB antigens was observed among individuals categorised as not Mtb -infected. • A large follow-up study with a clinical outcome in a setting with high TB transmission. • Findings are not influenced by cross-reactions attributed to non tuberculous mycobacteria.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2016.09.047